Garnett R, Fairman R P, Glauser F L
Department of Internal Medicine, Medical College of Virginia/McGuire Veterans Administration Hospitals, Richmond 23298-0001.
Am J Med Sci. 1987 Nov;294(5):317-23. doi: 10.1097/00000441-198711000-00005.
Ethchlorvynol injection in humans leads to a clinical picture consistent with increased permeability pulmonary edema, ie, the adult respiratory distress syndrome. There has been only one such case reported in which the pulmonary wedge pressure was measured. In an attempt to mimic the human disease, the authors established the awake, unanesthetized chronic sheep lung lymph fistula model and injected 15 mg/kg of ethchlorvynol intravenously after a baseline period. There were transient increases in pulmonary artery and systemic blood pressure with decreases in cardiac output. Lymph flow increased five-fold and remained elevated for 24 hr, returning to normal by 48 hr. All animals survived. Pulmonary morphologic changes consisted of alveolar and interstitial edema and some disruption of endothelial and epithelial cells. These findings resolved by 48 hr postinjection. The authors conclude that this model mimics the findings in humans who have injected ethchlorvynol intravenously.
人静脉注射ethchlorvynol会导致与通透性增加性肺水肿(即成人呼吸窘迫综合征)相符的临床表现。仅报告过1例测量了肺楔压的此类病例。为了模拟人类疾病,作者建立了清醒、未麻醉的慢性绵羊肺淋巴瘘模型,并在基线期后静脉注射15mg/kg的ethchlorvynol。肺动脉和全身血压出现短暂升高,心输出量降低。淋巴流量增加了五倍,并在24小时内保持升高,48小时后恢复正常。所有动物均存活。肺部形态学变化包括肺泡和间质水肿以及内皮细胞和上皮细胞的一些破坏。这些发现于注射后48小时消退。作者得出结论,该模型模拟了静脉注射ethchlorvynol的人类的表现。